DB

Daniel Bajek

Director, Financial Reporting at Intercept Pharmaceuticals

Daniel Bajek has extensive work experience in financial reporting and management. Daniel started their career at PwC in 2009 as an Associate and worked their way up to become a Senior Associate in 2012 and a Manager in 2015. Daniel was responsible for various financial and accounting tasks during their time at PwC. In 2018, Daniel joined Intercept Pharmaceuticals as an Associate Director of Financial Reporting. Daniel later became the Director of Financial Reporting in February 2021. Daniel's expertise lies in financial reporting and they have a strong background in the field.

Daniel Bajek completed their Bachelor of Science (B.S.) degree in Accounting at Rutgers University - Newark from 2005 to 2009. Following that, they pursued a Master of Accountancy in Financial Accounting at Rutgers University–New Brunswick from 2009 to 2010. In addition, they hold a CPA certification, although specific details regarding the institution, month, and year of obtaining the certification are not available.

Location

New Jersey, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Intercept Pharmaceuticals

1 followers

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases.